Role of tPA in Corticosterone-Induced Apoptosis of Mouse Mural Granulosa and Oviductal Epithelial Cells

Cells. 2023 Jan 31;12(3):455. doi: 10.3390/cells12030455.

Abstract

Although studies indicate that female stress-increased secretion of glucocorticoids impairs oocyte competence and embryo development, by inducing apoptosis of ovarian and oviductal cells, respectively, the mechanisms by which glucocorticoids induce apoptosis of ovarian and oviductal cells are largely unclear. Tissue plasminogen activator (tPA) has been involved in apoptosis of different cell types. However, while some studies indicate that tPA is proapoptotic, others demonstrate its antiapoptotic effects. This study has explored the role and action mechanisms of tPA in corticosterone-induced apoptosis of mouse mural granulosa cells (MGCs) and oviductal epithelial cells (OECs). The results demonstrate that culture with corticosterone significantly increased apoptosis, while decreasing levels of tPA (Plat) mRNA and tPA protein in both MGCs and OECs. Culture with tPA ameliorated corticosterone-induced apoptosis of MGCs and OECs. Furthermore, while tPA protected MGCs from corticosterone-induced apoptosis by interacting with low-density lipoprotein receptor-related protein 1 (LRP1), it protected OECs from the apoptosis by acting on Annexin 2 (ANXA2). In conclusion, tPA is antiapoptotic in both MGCs and OECs, and it protects MGCs and OECs from corticosterone-induced apoptosis by interacting with LRP1 and ANXA2, respectively, suggesting that tPA may use different receptors to inhibit apoptosis in different cell types.

Keywords: apoptosis; glucocorticoids; mural granulosa cell; oviductal epithelial cell; tissue plasminogen activator.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis
  • Corticosterone* / pharmacology
  • Epithelial Cells / metabolism
  • Female
  • Glucocorticoids* / pharmacology
  • Mice
  • Tissue Plasminogen Activator / metabolism

Substances

  • Corticosterone
  • Glucocorticoids
  • Tissue Plasminogen Activator

Grants and funding

This study was supported by grants from the China National Natural Science Foundation (Nos. 32072738, 31902160, 31772599 and 31702114), and the Natural Science Foundation of Shandong Province (No. ZR2022MC036).